Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

Cited In for PubMed (Select 21685363)


Yes-associated protein (YAP) is a negative regulator of chondrogenesis in mesenchymal stem cells.

Karystinou A, Roelofs AJ, Neve A, Cantatore FP, Wackerhage H, De Bari C.

Arthritis Res Ther. 2015 May 30;17:147. doi: 10.1186/s13075-015-0639-9.


Structural determinants of Smad function in TGF-β signaling.

Macias MJ, Martin-Malpartida P, Massagué J.

Trends Biochem Sci. 2015 Jun;40(6):296-308. doi: 10.1016/j.tibs.2015.03.012. Epub 2015 Apr 29. Review.


Structure of the N-terminal domain of the protein Expansion: an 'Expansion' to the Smad MH2 fold.

Beich-Frandsen M, Aragón E, Llimargas M, Benach J, Riera A, Pous J, Macias MJ.

Acta Crystallogr D Biol Crystallogr. 2015 Apr;71(Pt 4):844-53. doi: 10.1107/S1399004715001443. Epub 2015 Mar 26.


Versatile communication strategies among tandem WW domain repeats.

Dodson EJ, Fishbain-Yoskovitz V, Rotem-Bamberger S, Schueler-Furman O.

Exp Biol Med (Maywood). 2015 Mar;240(3):351-60. doi: 10.1177/1535370214566558. Epub 2015 Feb 20. Review.


bHLH proteins involved in Drosophila neurogenesis are mutually regulated at the level of stability.

Kiparaki M, Zarifi I, Delidakis C.

Nucleic Acids Res. 2015 Mar 11;43(5):2543-59. doi: 10.1093/nar/gkv083. Epub 2015 Feb 18.


WW domains of the yes-kinase-associated-protein (YAP) transcriptional regulator behave as independent units with different binding preferences for PPxY motif-containing ligands.

Iglesias-Bexiga M, Castillo F, Cobos ES, Oka T, Sudol M, Luque I.

PLoS One. 2015 Jan 21;10(1):e0113828. doi: 10.1371/journal.pone.0113828. eCollection 2015.


FGF8 promotes colorectal cancer growth and metastasis by activating YAP1.

Liu R, Huang S, Lei Y, Zhang T, Wang K, Liu B, Nice EC, Xiang R, Xie K, Li J, Huang C.

Oncotarget. 2015 Jan 20;6(2):935-52.


Ligand binding to WW tandem domains of YAP2 transcriptional regulator is under negative cooperativity.

Schuchardt BJ, Mikles DC, Hoang LM, Bhat V, McDonald CB, Sudol M, Farooq A.

FEBS J. 2014 Dec;281(24):5532-51. doi: 10.1111/febs.13095. Epub 2014 Nov 4.


Signaling mechanisms of the epithelial-mesenchymal transition.

Gonzalez DM, Medici D.

Sci Signal. 2014 Sep 23;7(344):re8. doi: 10.1126/scisignal.2005189. Review.


New gene evolution in the bonus-TIF1-γ/TRIM33 family impacted the architecture of the vertebrate dorsal-ventral patterning network.

Wisotzkey RG, Quijano JC, Stinchfield MJ, Newfeld SJ.

Mol Biol Evol. 2014 Sep;31(9):2309-21. doi: 10.1093/molbev/msu175. Epub 2014 May 31.


Selective small molecule compounds increase BMP-2 responsiveness by inhibiting Smurf1-mediated Smad1/5 degradation.

Cao Y, Wang C, Zhang X, Xing G, Lu K, Gu Y, He F, Zhang L.

Sci Rep. 2014 May 14;4:4965. doi: 10.1038/srep04965.


Molecular mechanisms of epithelial-mesenchymal transition.

Lamouille S, Xu J, Derynck R.

Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96. doi: 10.1038/nrm3758. Review.


Molecular basis of the binding of YAP transcriptional regulator to the ErbB4 receptor tyrosine kinase.

Schuchardt BJ, Bhat V, Mikles DC, McDonald CB, Sudol M, Farooq A.

Biochimie. 2014 Jun;101:192-202. doi: 10.1016/j.biochi.2014.01.011. Epub 2014 Jan 25.


The cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity via direct binding.

Ferguson BW, Gao X, Zelazowski MJ, Lee J, Jeter CR, Abba MC, Aldaz CM.

BMC Cancer. 2013 Dec 11;13:593. doi: 10.1186/1471-2407-13-593.


α-Catenin interacts with APC to regulate β-catenin proteolysis and transcriptional repression of Wnt target genes.

Choi SH, Estarás C, Moresco JJ, Yates JR 3rd, Jones KA.

Genes Dev. 2013 Nov 15;27(22):2473-88. doi: 10.1101/gad.229062.113.


PI3K-GSK3 signalling regulates mammalian axon regeneration by inducing the expression of Smad1.

Saijilafu, Hur EM, Liu CM, Jiao Z, Xu WL, Zhou FQ.

Nat Commun. 2013;4:2690. doi: 10.1038/ncomms3690.


Aberrant activation, nuclear localization, and phosphorylation of Yes-associated protein-1 in the embryonic kidney and Wilms tumor.

Murphy AJ, Pierce J, de Caestecker C, Libes J, Neblett D, de Caestecker M, Perantoni AO, Tanigawa S, Anderson JR, Dome JS, Das A, Carroll TJ, Lovvorn HN 3rd.

Pediatr Blood Cancer. 2014 Feb;61(2):198-205. doi: 10.1002/pbc.24788. Epub 2013 Sep 20.


OTUB1 enhances TGFβ signalling by inhibiting the ubiquitylation and degradation of active SMAD2/3.

Herhaus L, Al-Salihi M, Macartney T, Weidlich S, Sapkota GP.

Nat Commun. 2013;4:2519. doi: 10.1038/ncomms3519.


Regulation of the Hippo pathway and implications for anticancer drug development.

Park HW, Guan KL.

Trends Pharmacol Sci. 2013 Oct;34(10):581-9. doi: 10.1016/ Epub 2013 Sep 16. Review.


Differential topical susceptibility to TGFβ in intact and injured regions of the epithelium: key role in myofibroblast transition.

Speight P, Nakano H, Kelley TJ, Hinz B, Kapus A.

Mol Biol Cell. 2013 Nov;24(21):3326-36. doi: 10.1091/mbc.E13-04-0220. Epub 2013 Sep 4.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk